Astaxanthin, a Marine Carotenoid, Maintains the Tolerance and Integrity of Adipose Tissue and Contributes to Its Healthy Functions.
Allah NawazYasuhiro NishidaAkiko TakikawaShiho FujisakaTomonobu KadoAminuddin AminuddinMuhammad BilalIshtiaq JeelaniMuhammad Rahil AslamAyumi NishimuraTakahide KuwanoYoshiyuki WatanabeYoshiko IgarashiKeisuke OkabeSaeed AhmedAzhar ManzoorIsao UsuiKunimasa YagiTakashi NakagawaKazuyuki TobePublished in: Nutrients (2021)
Recently, obesity-induced insulin resistance, type 2 diabetes, and cardiovascular disease have become major social problems. We have previously shown that Astaxanthin (AX), which is a natural antioxidant, significantly ameliorates obesity-induced glucose intolerance and insulin resistance. It is well known that AX is a strong lipophilic antioxidant and has been shown to be beneficial for acute inflammation. However, the actual effects of AX on chronic inflammation in adipose tissue (AT) remain unclear. To observe the effects of AX on AT functions in obese mice, we fed six-week-old male C57BL/6J on high-fat-diet (HFD) supplemented with or without 0.02% of AX for 24 weeks. We determined the effect of AX at 10 and 24 weeks of HFD with or without AX on various parameters including insulin sensitivity, glucose tolerance, inflammation, and mitochondrial function in AT. We found that AX significantly reduced oxidative stress and macrophage infiltration into AT, as well as maintaining healthy AT function. Furthermore, AX prevented pathological AT remodeling probably caused by hypoxia in AT. Collectively, AX treatment exerted anti-inflammatory effects via its antioxidant activity in AT, maintained the vascular structure of AT and preserved the stem cells and progenitor's niche, and enhanced anti-inflammatory hypoxia induction factor-2α-dominant hypoxic response. Through these mechanisms of action, it prevented the pathological remodeling of AT and maintained its integrity.
Keyphrases
- insulin resistance
- high fat diet
- adipose tissue
- oxidative stress
- type diabetes
- metabolic syndrome
- diabetic rats
- high fat diet induced
- stem cells
- cardiovascular disease
- skeletal muscle
- anti inflammatory
- polycystic ovary syndrome
- dna damage
- healthcare
- clinical trial
- drug induced
- ischemia reperfusion injury
- glycemic control
- high glucose
- randomized controlled trial
- liver failure
- cardiovascular risk factors
- mesenchymal stem cells
- weight gain
- induced apoptosis
- stress induced
- blood glucose
- respiratory failure
- replacement therapy
- extracorporeal membrane oxygenation
- hepatitis b virus